# PharmaCyte Biotech, Inc.: Form 8-K, filed May 11, 2023

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: 8-K
- Filed: 2023-05-11
- Accepted by EDGAR: May 11, 2023, 12:30 ET
- Period: 2023-05-09
- Accession: 0001683168-23-003169
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000168316823003169/pharmacyte_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000168316823003169/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000168316823003169/pharmacyte_8k.htm

Filed May 11, 2023.
Source: SEC EDGAR, the filing index for accession 0001683168-23-003169. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.